Sub-Hertz Analysis of Viscoelasticity of Limbs in Patients With Lymphedema
1 other identifier
interventional
90
1 country
2
Brief Summary
Researchers are trying to validate the use of ultrasound sub-hertz analysis of viscoelastisty (SAVE) method to monitor tissue-fluid dynamics and stage disease severity in patients diagnosed with lymphedema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 6, 2020
CompletedStudy Start
First participant enrolled
July 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
ExpectedAugust 14, 2025
August 1, 2025
5.9 years
February 4, 2020
August 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Viscoelasticity parameters with lymphedema as obtained using the SAVE method
Defined as the difference in viscoelastic parameters between the arm affected with lymphedema and the unaffected extremity (affected minus unaffected) using the sub-hertz analysis of viscoelasticity method
Baseline
Study Arms (2)
Affected (Lymphedema)
EXPERIMENTALSubjects affected lymphedema extremity will have elastic and viscoelastic parameters collected by ultrasound procedure
Unaffected (Control)
ACTIVE COMPARATORSubjects unaffected extremity will have elastic and viscoelastic parameters collected by ultrasound procedure
Interventions
Ultrasound technique that uses a compression device integrated with ultrasound imaging to perform in vivo ramp-and-hold uniaxial creep-like test on upper extremity lymphedema (UEL) in vivo.
Eligibility Criteria
You may qualify if:
- Adult (18+ years of age)
- Ability to provide written consent
- Has been diagnosed with Lymphedema
You may not qualify if:
- Under the age of 18 years old
- Inability to provide written consent
- Previous lymphovenous bypass or lymph node transfer surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (2)
Mayo Clinic
Jacksonville, Florida, 32224, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Forte, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 4, 2020
First Posted
February 6, 2020
Study Start
July 6, 2020
Primary Completion
June 1, 2026
Study Completion (Estimated)
June 1, 2028
Last Updated
August 14, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share